Cargando…

Calprotectin (S100A8/S100A9) detects inflammatory activity in rheumatoid arthritis patients receiving tocilizumab therapy

BACKGROUND: Assessing serological inflammation is difficult in tocilizumab (TCZ)-treated rheumatoid arthritis (RA) patients, as standard inflammation parameters, like erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP), are influenced by interleukin-6-receptor inhibition. Calprotectin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gernert, Michael, Schmalzing, Marc, Tony, Hans-Peter, Strunz, Patrick-Pascal, Schwaneck, Eva Christina, Fröhlich, Matthias
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9389811/ https://www.ncbi.nlm.nih.gov/pubmed/35986420 http://dx.doi.org/10.1186/s13075-022-02887-7

Ejemplares similares

From bench to bedside: Calprotectin (S100A8/S100A9) as a biomarker in rheumatoid arthritis
por: Inciarte-Mundo, José, et al.
Publicado: (2022)

Tocilizumab in Large Vessel Vasculitis – Different Routes of Administration
por: Schmalzing, Marc, et al.
Publicado: (2018)

Lymphocyte subsets in the peripheral blood are disturbed in systemic sclerosis patients and can be changed by immunosuppressive medication
por: Gernert, Michael, et al.
Publicado: (2021)

Serum calprotectin (S100A8/9): an independent predictor of ultrasound synovitis in patients with rheumatoid arthritis
por: Hurnakova, Jana, et al.
Publicado: (2015)

High Prevalence of Genital Human Papillomavirus Infection in Patients With Primary Immunodeficiencies
por: Gernert, Michael, et al.
Publicado: (2021)

Low B cell counts as risk factor for infectious complications in systemic sclerosis after autologous hematopoietic stem cell transplantation
por: Gernert, Michael, et al.
Publicado: (2020)

Immunosuppressive Therapy After Autologous Hematopoietic Stem Cell Transplantation in Systemic Sclerosis Patients—High Efficacy of Rituximab
por: Gernert, Michael, et al.
Publicado: (2022)

S-Calprotectin (S100A8/S100A9): A Potential Marker of Inflammation in Patients with Psoriatic Arthritis
por: Hansson, Claes, et al.
Publicado: (2014)

Autologous Stem Cell Transplantation in Common Variable Immunodeficiency: A Case of Successful Treatment of Severe Refractory Autoimmune Encephalitis
por: Froehlich, Matthias, et al.
Publicado: (2020)

Extraction, isolation, and concentration of calprotectin antigen (S100A8/S100A9) from granulocytes
por: Nilsen, Tom, et al.
Publicado: (2018)

Calprotectin (S100A8/A9) in Familial Mediterranean Fever
por: Pepper, R, et al.
Publicado: (2015)

An Inflammation Loop Orchestrated by S100A9 and Calprotectin Is Critical for Development of Arthritis
por: Cesaro, Annabelle, et al.
Publicado: (2012)

Calprotectin (S100A8/S100A9) and Myeloperoxidase: Co-Regulators of Formation of Reactive Oxygen Species
por: Bøyum, Arne, et al.
Publicado: (2010)

Immunological Adverse Events After Autologous Hematopoietic Stem Cell Transplantation in Systemic Sclerosis Patients
por: Strunz, Patrick-Pascal, et al.
Publicado: (2021)

Decreases in serum levels of S100A8/9 (calprotectin) correlate with improvements in total swollen joint count in patients with recent-onset rheumatoid arthritis
por: Andrés Cerezo, Lucie, et al.
Publicado: (2011)

Circulating calprotectin (S100A8/A9) is higher in rheumatoid arthritis patients that relapse within 12 months of tapering anti-rheumatic drugs
por: de Moel, Emma C., et al.
Publicado: (2019)

Involvement of calprotectin (S100A8/A9) in molecular pathways associated with HNSCC
por: Khammanivong, Ali, et al.
Publicado: (2016)

Autologous hematopoietic stem cell transplantation in systemic sclerosis induces long-lasting changes in B cell homeostasis toward an anti-inflammatory B cell cytokine pattern
por: Gernert, Michael, et al.
Publicado: (2019)

Predictive value of serum calprotectin (S100A8/A9) for clinical response after starting or tapering anti-TNF treatment in patients with rheumatoid arthritis
por: Tweehuysen, Lieke, et al.
Publicado: (2018)

Relationship between serum calprotectin (S100A8/9) and clinical, laboratory and ultrasound parameters of disease activity in rheumatoid arthritis: A large cohort study
por: Hurnakova, Jana, et al.
Publicado: (2017)

Induction of IL-9 in Peripheral Lymphocytes of Rheumatoid Arthritis Patients and Healthy Donors by Th17-Inducing Cytokine Conditions
por: Heim, Jana, et al.
Publicado: (2021)

Apps in der Rheumatologie: Bedarf es einer App in der Therapie der axialen Spondyloarthritis?
por: Strunz, Patrick-Pascal, et al.
Publicado: (2021)

Association of serum calprotectin (S100A8/A9) concentrations and idiopathic hyperlipidemia in Miniature Schnauzers
por: Heilmann, Romy M., et al.
Publicado: (2019)

Patient-reported outcomes provide evidence for increased depressive symptoms and increased mental impairment in giant cell arteritis
por: Froehlich, Matthias, et al.
Publicado: (2023)

Serum calprotectin (S100A8/A9): a promising biomarker in diagnosis and follow-up in different subgroups of juvenile idiopathic arthritis
por: La, Céline, et al.
Publicado: (2021)

Expression and Function of S100A8/A9 (Calprotectin) in Human Typhoid Fever and the Murine Salmonella Model
por: De Jong, Hanna K., et al.
Publicado: (2015)

Diagnostic Value of Fecal Calprotectin (S100 A8/A9) Test in Children with Chronic Abdominal Pain
por: Pieczarkowski, Stanisław, et al.
Publicado: (2016)

Changes in Calprotectin (S100A8-A9) and Aldolase in the Saliva of Horses with Equine Gastric Ulcer Syndrome
por: Muñoz-Prieto, Alberto, et al.
Publicado: (2023)

The Role of Calprotectin in Rheumatoid Arthritis
por: Wang, Qin, et al.
Publicado: (2019)

Calprotectin (S100A8/9) as serum biomarker for clinical response in proof-of-concept trials in axial and peripheral spondyloarthritis
por: Turina, Maureen C, et al.
Publicado: (2014)

The soluble biomarker calprotectin (a S100 protein) is associated to ultrasonographic synovitis scores and is sensitive to change in patients with rheumatoid arthritis treated with adalimumab
por: Hammer, Hilde Berner, et al.
Publicado: (2011)

S100A8 and S100A9 in experimental osteoarthritis
por: Zreiqat, Hala, et al.
Publicado: (2010)

Role of the S100 protein family in rheumatoid arthritis
por: Wu, Yuan-yuan, et al.
Publicado: (2022)

Erdheim-Chester disease with Rosai-Dorfman-like lesions: treatment with methotrexate, anakinra and upadacitinib
por: Portegys, Jan, et al.
Publicado: (2023)

Calprotectin (S100A8/A9) has the strongest association with ultrasound-detected synovitis and predicts response to biologic treatment: results from a longitudinal study of patients with established rheumatoid arthritis
por: Nordal, Hilde Haugedal, et al.
Publicado: (2017)

S100A8/A9 as a biomarker for synovial inflammation and joint damage in patients with rheumatoid arthritis
por: Kang, Kwi Young, et al.
Publicado: (2014)

Minimal disease activity is a stable measure of therapeutic response in psoriatic arthritis patients receiving treatment with adalimumab
por: Behrens, Frank, et al.
Publicado: (2018)

Pneumococcal polysaccharide vaccination in rheumatoid arthritis patients receiving tocilizumab therapy
por: Mori, Shunsuke, et al.
Publicado: (2013)

Sustained improvement in work outcomes in employed patients with rheumatoid arthritis during 2 years of adalimumab therapy: an observational cohort study
por: Behrens, Frank, et al.
Publicado: (2020)

Vesicular Location and Transport of S100A8 and S100A9 Proteins in Monocytoid Cells
por: Chakraborty, Paramita, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_e4i7kmvb4joc8vrv3k08fb0sdp